Tango Therapeutics, Inc. (TNGX)
22.38
-0.46
(-2.04%)
USD |
NASDAQ |
Sep 01, 16:00
22.38
0.00 (0.00%)
After-Hours: 16:32
Tango Therapeutics Total Long Term Debt (Quarterly) : 29.05M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 29.05M |
| March 31, 2026 | 29.96M |
| December 31, 2025 | 30.83M |
| September 30, 2025 | 31.66M |
| June 30, 2025 | 32.47M |
| March 31, 2025 | 34.12M |
| December 31, 2024 | 34.04M |
| September 30, 2024 | 34.76M |
| June 30, 2024 | 35.47M |
| March 31, 2024 | 36.17M |
| December 31, 2023 | 36.84M |
| September 30, 2023 | 37.47M |
| June 30, 2023 | 38.08M |
| Date | Value |
|---|---|
| March 31, 2023 | 38.74M |
| December 31, 2022 | 39.36M |
| September 30, 2022 | 39.95M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 6.089M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 6.925M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.174B |
| Erasca, Inc. | 39.27M |
| NovelStem International Corp. | 1.620M |
| Brainstorm Cell Therapeutics, Inc. | 0.00 |
| Summit Therapeutics, Inc. | 16.83M |